Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAMBO: Fluoxetine for Motor Recovery Post-Stroke
NCT03728153Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in ischemic stroke, sponsored by Massachusetts General Hospital. Started Nov 2019; status: completed.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03728153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728153.